Potential therapeutic effect of Shufeng Jiedu capsule and its major herbs on coronavirus disease 2019 (COVID-19): A review-Reference-Cited by-同舟云学术

Potential therapeutic effect of Shufeng Jiedu capsule and its major herbs on coronavirus disease 2019 (COVID-19): A review

Published:2021-12-31 Issue:6 Volume:15 Page:289-299
ISSN:1881-7831
Container-title:Drug Discoveries & Therapeutics
language:en
Short-container-title:DD&T

Author:

Xu Yayun¹,Yang Li²,Wang Longfei³,Chen Feihu¹

Affiliation:

1. Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei, China.

2. School of food and biological engineering, Hefei University of Technology, Hefei, China.

3. Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei, China.

Publisher

International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,General Medicine

Link

https://www.jstage.jst.go.jp/article/ddt/15/6/15_2021.01099/_pdf

Reference84 articles.

1. 1. Bok K, Sitar S, Graham B, Mascola J. Accelerated COVID-19 vaccine development: milestones, lessons, and prospects. Immunity. 2021; 54:1636-1651.

2. 2. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395:497-506.

3. 3. Chakraborty C, Sharma A, Sharma G, Bhattacharya M, Lee S. SARS-CoV-2 causing pneumonia-associated respiratory disorder (COVID-19): diagnostic and proposed therapeutic options. Eur Rev Med Pharmacol Sci. 2020; 24:4016-4026.

4. 4. Salvi R, Patankar P. Emerging pharmacotherapies for COVID-19. Biomed Pharmacother. 2020; 128:110267.

5. 5. Dong L, Hu S, Gao J. Discovering drugs to treat coronavirus disease 2019 (COVID-19). Drug Discov Ther. 2020; 14:58-60.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chinese herbal medicine Shufeng Jiedu Capsule for patients with mild to moderate coronavirus disease 2019 (COVID-19): Protocol for a randomized, blinded, placebo control trial;European Journal of Integrative Medicine;2023-09

2. Recent advances in Chinese patent medicines entering the international market;Drug Discoveries & Therapeutics;2022-12-25

3. Shufeng Jiedu capsule inhibits inflammation and apoptosis by activating A2AAR and inhibiting NF-κB to alleviate LPS-induced ALI;Journal of Ethnopharmacology;2022-11